miR-106b targets the tumor suppressor gene phosphatase and tensin homolog (PTEN), thereby modulating AKT/mTOR signaling pathway and ultimately inhibiting the proliferation of endometrial cancer cells (59). This evidence concerns the gene PTEN and endometrial cancer.